MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Up 93.4% in July

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 3,170 shares, an increase of 93.4% from the June 30th total of 1,639 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average daily trading volume, of 1,140 shares, the short-interest ratio is presently 2.8 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of MDB Capital in a report on Thursday, July 2nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

MDB Capital Stock Down 0.8%

Shares of MDBH traded down $0.02 during mid-day trading on Friday, reaching $3.04. The company’s stock had a trading volume of 1,940 shares, compared to its average volume of 1,183. The company has a market cap of $31.27 million, a price-to-earnings ratio of -1.43 and a beta of 1.17. The business has a fifty day moving average of $3.23 and a 200 day moving average of $3.29. MDB Capital has a 1 year low of $2.45 and a 1 year high of $4.80.

MDB Capital (NASDAQ:MDBH) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($0.65) earnings per share for the quarter.

Hedge Funds Weigh In On MDB Capital

A number of large investors have recently made changes to their positions in MDBH. DRW Securities LLC acquired a new stake in shares of MDB Capital during the fourth quarter worth approximately $40,000. Citadel Advisors LLC purchased a new position in MDB Capital during the third quarter valued at approximately $43,000. Finally, Raymond James Financial Inc. acquired a new position in MDB Capital in the 2nd quarter valued at approximately $27,000. Institutional investors and hedge funds own 0.35% of the company’s stock.

MDB Capital Company Profile

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.